Implementing a Combination of Clinical Parameters, Biomarkers and SoCs for the Etiology Diagnoses of Pneumonia in Pediatric Patients

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

188 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-07-04

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Participants who meet the inclusion and exclusion criteria will be enrolled and then having a daily follow up for maximum of 13 days' hospitalization. Next follow up will be taken time at day 14th after hospitalization date, either on ward or policlinic. The participations will be ended by day 30th after hospitalization date when the called follow up is done by investigator.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia

NCT03996967

Pneumonia, Bacterial Viral Infection Clinical Pneumonia +3 more

COMPLETED

Observational Research on Infectious Disease Outbreaks and Difficult Cases of Unidentified Etiology in Indonesia

NCT04339179

Infectious Disease

COMPLETED

Rapid Diagnosis of Severe Respiratory Tract Infectious Diseases and Screening of Biomarkers for Stratified Diagnosis

NCT06533514

Severe Pneumonia Biomarkers

NOT_YET_RECRUITING

Roles of Some Non-classic Biomarkers in Pediatric Pneumonia

NCT05701605

Pneumonia in Children

UNKNOWN

Innovative Treatments in Pneumonia (ITIP) 3

NCT02960919

Pneumonia

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will collect demographic data, medical history, clinical data, treatment, and risk factors of pneumonia. The study also record the supporting examination results include but not limited to Complete Blood Count (CBC) results, blood gas analyses result, CRP, PCT, culture result, rapid test for influenza, Respiratory Syncytial Virus (RSV), legionella, and chest X-ray. In order to produce a robust data, this study will conduct the serological and molecular tests at the reference laboratory.

Whole blood, serum, urine, Nasal Pharyngeal Swab (NPS), sputum/induced sputum, and other respiratory specimens (if available) will be collected for storage and testing at enrollment. Plasma from 48-72 hours after hospitalization and left-over respiratory specimens on day 2 and 3 of hospitalization will also be collected to be stored. For additional, at day 14th after hospitalization serum will be processed from 4 mL of blood for archiving and testing at the reference laboratory.

This study will be conducted at following INA-RESPOND sites:

* RSU Kabupaten Tangerang, Tangerang
* RSUP Dr. Kariadi, Semarang
* RSUP Dr. Sardjito, Yogyakarta RSU Kabupaten Tangerang located in Banten province is type B or district referral hospital. While RSUP Dr Kariadi in Semarang and RSUP Dr Sardjito in Yogyakarta are type A hospital which is a level of province referral. Maximum duration for participants' accrual will be 2 years since the first participant enrolled. However, the study laboratory testing may take up to 6 months to be completed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pneumonia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pediatric inpatients whose ages range from 2 months to 5 years
* Meet the case definition for pneumonia which is cough or fever with at least one other following symptoms:

* Shortness of breath
* Tachypnea
* Grunting
* Crackles/rhonchi
* Decreased vesicular breath sound
* Bronchial breath sound
* Chest x-ray consistent with pneumonia
* Comply with all study procedures including to store required specimens for diagnostic testing and archiving.

Exclusion Criteria

* Being Hospitalized for more than 24 hours at enrollment
* Having a cancer or history of cancer
* Having a history of long term exposed of steroid (at the minimum of 2 months)
* Having any condition that might interfere with study procedure and compliance (based on clinicians' judgement)

Minimum Eligible Age

2 Months

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No